This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Greenwald J, Freeman GJ, Sharpe AH . The B7 family revisited. Annu Rev Immunol 2005; 23: 515–548.
Nakae S, Suto H, Likura M, Kakurai M, Sedgwick JD, Tsai M et al. Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF. J Immunol 2006; 176: 2238–2248.
Butte MJ, Keir ME, Phamduy TB, Sharpe AH, Freeman GJ . Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses. Immunity 2007; 27: 111–122.
Zhang Y, Shengdong H, Gong D, Qin YH, Shen Q . Programmed death-1 upregulation in correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer. Cell Mol Immunol 2010; 7: 389–395.
Nishimura H, Nose M, Hiai H, Minato N, Honjo T . Development of lupus like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141–151.
Kasagi S, Kawano S, Okazaki T, Honjo T, Morinobu A, Hatachi S et al. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice. J Immunol 2010; 184: 2337–2347.
Kristjansdottir H, Steinsson K, Gunnarsson I, Gunnarsson I, Grondal G, Erlendsson K et al. Lower expression levels of the programmed death 1 receptor on CD4CD25 T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus. Arthritis Rheum 2010; 62: 1702–1711.
Ferreiros-Vidal I, Gomez-Reino J, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus. Arthritis Rheum 2004; 50: 2590–2597.
Prokunina L, Castillejo-López CÖ berg F, Gunnarsson I, Berg L, Magnusson V et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002; 32: 666–669.
Elbeldi-Ferchiou A, Ben Ahmed M, Smiti-Khanfir M, Houman MH, Abdeladhim M, Belhadj Hmida N et al. Resistance to exogenous TGF-β effects in patients with systemic lupus erythematosus. J Clin Immunol 2011; 31: 574–583.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rekik, R., Belhadj Hmida, N., Ben Hmid, A. et al. PD-1 induction through TCR activation is partially regulated by endogenous TGF-β. Cell Mol Immunol 12, 648–649 (2015). https://doi.org/10.1038/cmi.2014.104
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cmi.2014.104
This article is cited by
-
The 4-1BBζ costimulatory domain in chimeric antigen receptors enhances CD8+ T-cell functionality following T-cell receptor stimulation
Cancer Cell International (2023)
-
Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation
Journal of Hematology & Oncology (2022)
-
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
Nature Medicine (2022)
-
Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors
International Journal of Hematology (2021)
-
Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
Molecular Cancer (2019)